Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026

Core Viewpoint - Jazz Pharmaceuticals plc will report its fourth quarter and full year 2025 financial results on February 24, 2026, after U.S. market close, with a subsequent webcast for discussion and updates [1] Company Overview - Jazz Pharmaceuticals is a global biopharma company focused on innovating to transform the lives of patients with rare diseases, often providing limited or no therapeutic options [1] - The company has a diverse portfolio of medicines targeting conditions such as epilepsies, cancers, and sleep disorders, emphasizing a patient-focused and science-driven approach [1] - Jazz Pharmaceuticals is headquartered in Dublin, Ireland, with research and development labs, manufacturing facilities, and employees across multiple countries [1]